✦ LIBER ✦

Prevalence of anti-HCV antibodies in kidney allograft recipients with chronic B or non A non B hepatitis or without liver dysfunction

✍ Scribed by Lunel, F.; Jeannot, D.; Perrin, M.; Luciani, F.; Grippon, P.; Cadranel, J.F.; Devillechabrolle, A.; Jacobs, C.; Chatclain, C.; Opolon, P.

Book ID: 122966217
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 114 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)91725-C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-hepatitis C virus (HCV) antibodies

Anti-hepatitis C virus (HCV) antibodies in heart transplant recipients with posttransplantation chronic viral B and non-A, non-B hepatitis

✍ F Lunel; J. F. Cadranel; M. Perrin; P. Grippon; M. Desruenne; J. M. Huraux; C. C 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 130 KB

Anti-HCV antibodies in heart transplant

Anti-HCV antibodies in heart transplant recipients (HT) with post transplantation (PT) chronic viral B and non A non B (NANB) hepatitis

✍ Lunel, F.; Cadranel, J.F.; Perrin, M.; Grippon, P.; Desnienne, M.; Huraux, J.M.; 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Application of a numerical scoring syste

Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis with or without antibodies to hepatitis C

✍ Lars Mattsson; Ola Weiland; Hans Glaumann 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

Prevalence of hepatitis B and C viruses

Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: Low incidence of HCV infection

✍ Georgios N. Dalekos; Eleftheria Zervou; Markos H. Merkouropoulos; Epameinondas V 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 534 KB

Intravenous heroin abusers comprise a high risk group for hepatitis B and C viruses (HBV and HCV) infection. Chronic alcoholics with liver disease (LD) also comprise a high risk group for HBV infection whereas the frequency of antibodies to HCV (anti-HCV) ranges from 27-42.6%. In this study, HBV and

A randomized trial of high dose interfer

A randomized trial of high dose interferon alfa-2b with or without ribavirin for chronic hepatitis C in non-responders to standard dose interferon

✍ Shiva Kumar, K.; Malik, Arshad H.; Malet, Peter F.; Ostapowicz, George; Wood, Me 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB